Dr Shonraj Ballae, PhD, Head of Clinical Research, Remidio shares all you need to know Remidio has pioneered the development ...

This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is ...

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Artificial Intelligence (AI) could become a radiologist's best friend, with researchers training the technology to accurately ...

During a fireside chat at the annual J.P. Morgan Healthcare Conference on January 13th, Mayo Clinic chief administrative ...

Researchers have discovered a molecular signature of Long Covid in children, detectable through a blood test and diagnosable ...

A breakthrough new AI model is able to detect the presence of different lung diseases from ultrasound videos, with 96.57% ...

Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

Artificial intelligence (AI) in detecting breast cancer is advancing significantly, thanks to an innovative diagnostic method that identifies the disease even when traditional tests fail. This ...